Skip to content
Citation only via OpenAlex

EFFECTS OF TRANSIENT MID-LIFE RAPAMYCIN TREATMENT ON LIFESPAN AND HEALTHSPAN

Authors not listed

The Gerontologist · 2016

Abstract

EFFECTS OF TRANSIENT MID-LIFE mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">RAPAMYCIN(definition) TREATMENT ON LIFESPAN AND HEALTHSPAN(definition) M. Kaeberlein, Pathology, University of Washington, Seattle, Washington The FDA approved drug rapamycin has been shown to increase lifespan and healthspan in laboratory model organisms such as yeast, worms, flies and mice. In mice, treatment with rapamycin beginning at middle-age is sufficient to increase lifespan and improve measures of both cardiac and immune function. Nevertheless, important questions exist regarding the translational potential of rapamycin and other mTOR inhibitors for human aging, and the optimal dose, duration, and mechanisms of action remain to be determined. Here I will report on recent studies examining the effects of short-term treatment with rapamycin in middle-aged mice and dogs. We find that transient treatment with rapamycin is sufficient to increase life expectancy by more than 50% and improve measures of healthspan in middle-aged mice. At the highest dose tested, this transient treatment is also associated with a remodelling of the gut microbiome, along with a dramatic shift in the cancer spectrum in female mice. In dogs, we have defined a dose of rapamycin that is well tolerated, and initial results are consistent with improvements in age-associated cardiac function similar to those observed in rapamycin-treated mice. These data suggest that a transient treatment with rapamycin may yield robust health benefits in mice, dogs, and perhaps humans.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1093/geront/gnw162.2793
Canonical
link ↗
Fetched
2026-10-29 MST

Cite this

APA
Anonymous. (2016). EFFECTS OF TRANSIENT MID-LIFE RAPAMYCIN TREATMENT ON LIFESPAN AND HEALTHSPAN. <em>The Gerontologist</em>. https://doi.org/10.1093/geront/gnw162.2793
Vancouver
Anonymous. EFFECTS OF TRANSIENT MID-LIFE RAPAMYCIN TREATMENT ON LIFESPAN AND HEALTHSPAN. The Gerontologist. 2016. doi:10.1093/geront/gnw162.2793.
BibTeX
@article{anon2016EFFECT, title = {EFFECTS OF TRANSIENT MID-LIFE RAPAMYCIN TREATMENT ON LIFESPAN AND HEALTHSPAN}, author = {Anonymous}, journal = {The Gerontologist}, year = {2016}, doi = {10.1093/geront/gnw162.2793}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings